Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.31 trillion and total revenue of $109.84 billion.
Market Cap
1.31T
Revenue
109.84B
Profits
-41.29B
PE Ratio
n/a
Profit Margin
-37.59%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.01B | -0.39% | 2,107,131 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.96B | 0.76% | 671,232 | 14.92B |
| 3 | ARGX | argenx SE | 56.98B | -0.63% | 287,236 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.76B | -3.31% | 5,886,838 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.63B | 0.72% | 1,609,900 | - |
| 6 | ONC | BeOne Medicines AG | 33.67B | 0.31% | 134,161 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.38B | -0.70% | 3,272,548 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 30.38B | 3.74% | 4,411,478 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.48B | 2.00% | 5,397,846 | 8.26M |
| 10 | INSM | Insmed Incorporated | 25.63B | 1.48% | 3,166,980 | 819.56M |
| 11 | INCY | Incyte Corporation | 23.68B | 1.07% | 1,353,556 | 5.36B |
| 12 | BNTX | BioNTech SE | 23.51B | -0.59% | 816,163 | 3.23B |
| 13 | GMAB | Genmab A/S | 18.12B | 0.81% | 2,770,068 | 3.90B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 17.68B | 15.12% | 20,623,618 | 579.96M |
| 15 | ASND | Ascendis Pharma A/S | 17.11B | -0.63% | 667,121 | 998.25M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.51B | -0.54% | 713,508 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.35B | 1.76% | 2,511,635 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.91B | -0.95% | 379,018 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.81B | 1.38% | 621,686 | 708.24M |
| 20 | ABVX | ABIVAX Société Anonyme | 12.08B | 1.59% | 907,168 | 5.67M |
| 21 | SMMT | Summit Therapeutics Inc. | 12.01B | -1.34% | 2,365,790 | - |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.83B | -2.03% | 1,437,699 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 11.69B | 1.40% | 1,655,748 | 105.82M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | 0.37% | 946,749 | 3.24B |
| 25 | TECH | Bio-Techne Corporation | 11.09B | 0.27% | 4,715,237 | 1.21B |
| 26 | KRYS | Krystal Biotech, Inc. | 10.94B | -1.11% | 245,594 | 417.30M |
| 27 | IONS | Ionis Pharmaceuticals, Inc. | 10.62B | -23.90% | 20,447,628 | 1.06B |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.01B | 0.24% | 2,057,366 | - |
| 29 | CORT | Corcept Therapeutics Incorporated | 10.01B | 0.33% | 1,189,272 | 769.10M |
| 30 | NUVL | Nuvalent, Inc. | 9.82B | 0.02% | 1,479,241 | - |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.79B | 4.24% | 583,268 | 51.48M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 9.33B | -2.18% | 1,782,675 | 1.51B |
| 33 | IBRX | ImmunityBio, Inc. | 9.29B | 0.80% | 11,355,717 | 140.98M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 9.29B | 0.04% | 310,760 | 7.46M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.85B | -1.73% | 578,116 | 74.06M |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | 0.16% | 10,026,831 | 18.07M |
| 37 | PCVX | Vaxcyte, Inc. | 8.64B | 1.91% | 1,207,672 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 8.58B | 3.51% | 1,329,743 | - |
| 39 | IMVT | Immunovant, Inc. | 8.44B | 1.94% | 998,353 | - |
| 40 | TGTX | TG Therapeutics, Inc. | 8.37B | 3.20% | 1,555,850 | 700.35M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.91B | 0.92% | 586,048 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 7.79B | -0.68% | 695,519 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 7.43B | 1.11% | 1,269,803 | 827.11M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.94B | 3.41% | 811,309 | - |
| 45 | COGT | Cogent Biosciences, Inc. | 6.92B | 1.35% | 3,868,274 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 6.86B | 1.44% | 2,587,138 | 7.50M |
| 47 | CGON | CG Oncology, Inc. | 6.47B | 5.04% | 776,888 | 5.07M |
| 48 | DFTX | Definium Therapeutics, Inc. | 6.43B | 6.91% | 3,017,564 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 6.39B | 2.45% | 398,301 | 274.48M |
| 50 | BLTE | Belite Bio, Inc | 6.03B | 0.62% | 113,257 | - |
| 51 | ERAS | Erasca, Inc. | 5.96B | 1.64% | 4,199,736 | - |
| 52 | CELC | Celcuity Inc. | 5.54B | 4.23% | 983,877 | - |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 5.47B | 2.00% | 2,395,599 | 1.34M |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.44B | 0.19% | 1,428,437 | 536.20M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.43B | -4.83% | 1,436,246 | 4.10M |
| 56 | ORKA | Oruka Therapeutics, Inc. | 5.32B | 4.59% | 560,826 | - |
| 57 | LEGN | Legend Biotech Corporation | 5.30B | -1.76% | 1,400,757 | 1.14B |
| 58 | MANE | Veradermics, Incorporated | 5.22B | 5.63% | 315,683 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 5.20B | 4.43% | 1,590,606 | - |
| 60 | CAI | Caris Life Sciences, Inc. | 5.05B | 3.18% | 3,294,445 | 907.29M |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.78B | 2.95% | 1,722,342 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 4.52B | 1.58% | 1,729,446 | 1.10B |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.52B | 5.71% | 4,433,256 | 10.68M |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.41B | -0.39% | 2,746,978 | 56.99M |
| 65 | DNLI | Denali Therapeutics Inc. | 4.32B | 1.95% | 1,567,368 | - |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 4.20B | 0.25% | 884,099 | 22.57M |
| 67 | DYN | Dyne Therapeutics, Inc. | 4.01B | 1.85% | 1,764,439 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.99B | 1.99% | 169,935 | 803.79M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.92B | 0.46% | 459,919 | - |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.87B | -1.52% | 402,142 | - |
| 71 | ALMS | Alumis Inc. | 3.86B | 1.88% | 2,115,632 | 8.40M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | 1,196,368 | 596.96M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.77B | -0.99% | 753,380 | 236.00M |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.64B | 2.72% | 998,552 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.60B | 0.98% | 1,738,379 | 415.62M |
| 76 | BEAM | Beam Therapeutics Inc. | 3.57B | -2.87% | 2,508,825 | 164.01M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | -1.79% | 983,823 | 225.27M |
| 78 | RARE | Ultragenyx Pharmaceutical Inc. | 3.40B | -0.17% | 1,942,584 | 670.00M |
| 79 | MBX | MBX Biosciences, Inc. | 3.13B | 6.43% | 747,903 | - |
| 80 | CLDX | Celldex Therapeutics, Inc. | 3.06B | 0.05% | 612,467 | 865.00K |
| 81 | QURE | uniQure N.V. | 3.06B | 2.28% | 1,160,156 | 18.09M |
| 82 | VERA | Vera Therapeutics, Inc. | 3.05B | 0.05% | 2,751,167 | - |
| 83 | IRON | Disc Medicine, Inc. | 3.02B | -1.40% | 305,555 | - |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | -5.30% | 2,168,642 | 535.08M |
| 85 | IMNM | Immunome, Inc. | 2.74B | 0.67% | 1,207,033 | 4.02M |
| 86 | KLRA | Kailera Therapeutics, Inc. | 2.72B | -3.45% | 701,550 | - |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.66B | -1.82% | 7,059,507 | - |
| 88 | TRVI | Trevi Therapeutics, Inc. | 2.61B | -1.02% | 1,549,283 | - |
| 89 | NRIX | Nurix Therapeutics, Inc. | 2.55B | 1.56% | 1,344,872 | 71.78M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.55B | -4.74% | 1,265,617 | - |
| 91 | AGIO | Agios Pharmaceuticals, Inc. | 2.54B | 0.07% | 520,058 | 66.05M |
| 92 | BHVN | Biohaven Ltd. | 2.53B | 0.90% | 2,101,342 | - |
| 93 | PHVS | Pharvaris N.V. | 2.51B | 0.08% | 1,887,296 | - |
| 94 | KOD | Kodiak Sciences Inc. | 2.50B | -1.35% | 852,006 | - |
| 95 | VCEL | Vericel Corporation | 2.47B | 2.74% | 409,471 | 292.09M |
| 96 | NKTR | Nektar Therapeutics | 2.46B | 1.42% | 692,475 | 55.63M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.31B | 2.63% | 2,429,216 | 52.04M |
| 98 | ZLAB | Zai Lab Limited | 2.24B | 1.16% | 935,685 | 453.28M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 2.23B | 1.71% | 2,003,036 | 70.92M |
| 100 | ABCL | AbCellera Biologics Inc. | 2.23B | 2.68% | 5,915,679 | 79.21M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 0.34% | 607,825 | 899.11M |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 2.20B | 1.14% | 1,441,236 | 217.17M |
| 103 | KARD | Kardigan, Inc. | 2.18B | 10.04% | 247,787 | - |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | 1.53% | 3,008,296 | 2.18B |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.17B | 4.03% | 274,652 | - |
| 106 | NTLA | Intellia Therapeutics, Inc. | 2.16B | -8.31% | 7,387,646 | 66.09M |
| 107 | ADMA | ADMA Biologics, Inc. | 2.15B | 1.20% | 2,004,489 | 509.86M |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 2.22% | 1,589,479 | 298.30M |
| 109 | NUVB | Nuvation Bio Inc. | 2.13B | 4.09% | 8,861,388 | 143.05M |
| 110 | TSHA | Taysha Gene Therapies, Inc. | 2.10B | 1.23% | 2,227,195 | 7.47M |
| 111 | GLUE | Monte Rosa Therapeutics, Inc. | 2.07B | 1.91% | 1,199,706 | 42.95M |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.04B | 0.55% | 493,778 | 32.08M |
| 113 | SION | Sionna Therapeutics, Inc. | 2.03B | 2.14% | 697,997 | - |
| 114 | GENB | Generate Biomedicines, Inc. | 2.02B | -0.95% | 503,684 | 30.30M |
| 115 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 0.14% | 312,127 | 20.00M |
| 116 | LKFT | Lakefront Biotherapeutics NV | 2.01B | -0.71% | 119,133 | 1.20B |
| 117 | RXRX | Recursion Pharmaceuticals, Inc. | 2.00B | 1.08% | 22,293,569 | 66.41M |
| 118 | NBTX | Nanobiotix S.A. | 1.98B | 0.39% | 39,004 | 38.27M |
| 119 | ANAB | AnaptysBio, Inc. | 1.97B | 1.90% | 394,238 | 232.39M |
| 120 | PGEN | Precigen, Inc. | 1.97B | -0.54% | 2,989,079 | 31.60M |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.96B | 1.35% | 612,236 | - |
| 122 | ATAI | AtaiBeckley Inc. | 1.96B | 3.09% | 7,511,667 | 3.49M |
| 123 | URGN | UroGen Pharma Ltd. | 1.96B | 5.78% | 617,918 | 140.49M |
| 124 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 2.10% | 13,730,401 | 285.61M |
| 125 | BCAX | Bicara Therapeutics Inc. | 1.95B | 2.38% | 440,070 | - |
| 126 | ABSI | Absci Corporation | 1.94B | 3.33% | 4,970,931 | 1.84M |
| 127 | ZYME | Zymeworks Inc. | 1.94B | 1.58% | 598,095 | 81.26M |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.89B | 11.81% | 845,623 | - |
| 129 | MESO | Mesoblast Limited | 1.89B | 0.20% | 223,517 | 65.38M |
| 130 | GHRS | GH Research PLC | 1.87B | 1.30% | 499,556 | - |
| 131 | ZBIO | Zenas BioPharma, Inc. | 1.86B | 2.29% | 671,144 | 10.00M |
| 132 | MPLT | MapLight Therapeutics, Inc. | 1.80B | 3.30% | 664,409 | - |
| 133 | MAZE | Maze Therapeutics, Inc. | 1.79B | 1.34% | 584,905 | 20.00M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.74B | -0.86% | 1,285,216 | 65.50M |
| 135 | COAG | Hemab Therapeutics Holdings, Inc. | 1.74B | 9.77% | 313,403 | - |
| 136 | SEPN | Septerna, Inc. | 1.71B | 3.96% | 969,517 | 72.26M |
| 137 | IMCR | Immunocore Holdings plc | 1.68B | -2.07% | 655,790 | 412.81M |
| 138 | FTRE | Fortrea Holdings Inc. | 1.67B | 3.82% | 971,807 | 2.71B |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.65B | 4.51% | 1,530,831 | - |
| 140 | INVA | Innoviva, Inc. | 1.64B | -1.03% | 672,063 | 420.69M |
| 141 | AAPG | Ascentage Pharma Group International | 1.60B | 0.21% | 9,030 | 82.08M |
| 142 | SVRA | Savara Inc. | 1.60B | -1.41% | 1,509,035 | - |
| 143 | AKTS | Aktis Oncology, Inc. | 1.57B | -0.94% | 371,419 | 8.28M |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 0.81% | 378,497 | - |
| 145 | NVAX | Novavax, Inc. | 1.55B | 0.53% | 2,718,592 | 596.34M |
| 146 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.54B | 3.65% | 1,582,644 | 204.73M |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.52B | 6.95% | 678,696 | 1.30M |
| 148 | CRVS | Corvus Pharmaceuticals, Inc. | 1.36B | 0.75% | 1,067,564 | - |
| 149 | IMTX | Immatics N.V. | 1.36B | -0.20% | 280,578 | 43.00M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.33B | -0.22% | 646,395 | - |
| 151 | ARDX | Ardelyx, Inc. | 1.33B | -0.92% | 2,171,522 | 427.68M |
| 152 | CAPR | Capricor Therapeutics, Inc. | 1.30B | 1.12% | 1,169,150 | 11.13M |
| 153 | MGTX | MeiraGTx Holdings plc | 1.29B | -1.41% | 1,149,609 | 79.76M |
| 154 | AVLN | Avalyn Pharma Inc. | 1.28B | -0.07% | 228,660 | - |
| 155 | MNKD | MannKind Corporation | 1.28B | -2.59% | 3,358,418 | 360.78M |
| 156 | EYPT | EyePoint, Inc. | 1.24B | 5.92% | 1,570,801 | 7.61M |
| 157 | WVE | Wave Life Sciences Ltd. | 1.21B | 1.12% | 1,662,963 | 71.80M |
| 158 | XNCR | Xencor, Inc. | 1.19B | -2.10% | 1,245,456 | 97.36M |
| 159 | SANA | Sana Biotechnology, Inc. | 1.18B | -1.26% | 2,345,415 | - |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.17B | 1.56% | 407,443 | - |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 0.37% | 880,399 | - |
| 162 | TRAX | First Tracks Biotherapeutics, Inc. | 1.13B | 55.99% | 4,512,544 | - |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | -0.27% | 448,129 | - |
| 164 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -3.53% | 160,057 | - |
| 165 | SLDB | Solid Biosciences Inc. | 1.10B | 1.27% | 1,019,272 | - |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | 0.08% | 1,420,337 | - |
| 167 | KURA | Kura Oncology, Inc. | 1.07B | -0.33% | 1,414,362 | 71.64M |
| 168 | VOR | Vor Biopharma Inc. | 1.07B | -2.76% | 1,597,577 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 3.85% | 1,004,132 | 59.00K |
| 170 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.54% | 902,248 | 13.73M |
| 171 | ABUS | Arbutus Biopharma Corporation | 1.02B | -1.53% | 2,933,927 | 191.45M |
| 172 | PHAR | Pharming Group N.V. | 1.01B | -1.82% | 3,372 | 369.49M |
| 173 | IVA | Inventiva S.A. | 1.01B | 3.19% | 1,782,050 | 7.94M |
| 174 | GERN | Geron Corporation | 1.00B | - | 11,741,658 | 196.12M |
| 175 | LXRX | Lexicon Pharmaceuticals, Inc. | 999.44M | -0.88% | 1,465,319 | 69.64M |
| 176 | ANNX | Annexon, Inc. | 973.22M | -0.34% | 4,004,143 | - |
| 177 | ANRO | Alto Neuroscience, Inc. | 970.00M | 5.94% | 509,391 | - |
| 178 | LBRX | LB Pharmaceuticals Inc | 967.55M | -1.26% | 237,874 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 965.87M | 0.83% | 2,167,094 | 204.89M |
| 180 | DBVT | DBV Technologies S.A. | 964.06M | -4.00% | 109,735 | 5.74M |
| 181 | DSGN | Design Therapeutics, Inc. | 963.09M | 0.92% | 644,099 | - |
| 182 | TENX | Tenax Therapeutics, Inc. | 936.00M | 3.33% | 1,532,320 | - |
| 183 | REPL | Replimune Group, Inc. | 932.63M | -0.09% | 2,744,923 | - |
| 184 | FBRX | Forte Biosciences, Inc. | 896.79M | 78.33% | 4,866,521 | - |
| 185 | TBPH | Theravance Biopharma, Inc. | 880.04M | -0.12% | 439,915 | 109.78M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 861.02M | 3.26% | 2,164,608 | 35.54M |
| 187 | NGNE | Neurogene Inc. | 853.67M | 12.03% | 436,589 | 925.00K |
| 188 | FTH | Faeth Therapeutics, Inc. | 838.84M | 16.13% | 159,154 | - |
| 189 | OCS | Oculis Holding AG | 827.32M | - | 524,628 | 1.40M |
| 190 | ZVRA | Zevra Therapeutics, Inc. | 824.06M | -5.49% | 1,601,184 | 122.29M |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 809.65M | 1.93% | 320,107 | 299.77M |
| 192 | RGNX | REGENXBIO Inc. | 809.09M | 2.76% | 1,975,502 | 87.82M |
| 193 | ODTX | Odyssey Therapeutics, Inc. | 805.79M | 8.16% | 167,669 | 1.06M |
| 194 | ACRS | Aclaris Therapeutics, Inc. | 797.48M | 3.63% | 2,047,784 | 8.37M |
| 195 | CLYM | Climb Bio, Inc. | 791.34M | 1.84% | 1,255,148 | - |
| 196 | IMMX | Immix Biopharma, Inc. | 789.50M | 0.82% | 1,447,067 | - |
| 197 | SPRY | ARS Pharmaceuticals, Inc. | 782.51M | -2.72% | 1,155,796 | 98.99M |
| 198 | AURA | Aura Biosciences, Inc. | 772.10M | -3.45% | 682,505 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 764.81M | - | 61,022 | 117.05M |
| 200 | PRME | Prime Medicine, Inc. | 764.01M | -8.44% | 4,868,531 | 4.03M |
| 201 | DRUG | Bright Minds Biosciences Inc. | 762.82M | 11.91% | 218,808 | - |
| 202 | OMER | Omeros Corporation | 743.29M | 0.29% | 875,884 | 9.89M |
| 203 | SLBT | SL Science Holding Limited | 737.01M | 5.07% | 62,128 | - |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 728.17M | 0.78% | 558,851 | - |
| 205 | ALLO | Allogene Therapeutics, Inc. | 724.82M | -0.94% | 6,544,217 | 22.00K |
| 206 | CADL | Candel Therapeutics, Inc. | 724.64M | 0.10% | 1,101,674 | - |
| 207 | MNPR | Monopar Therapeutics Inc. | 700.02M | 5.27% | 336,753 | - |
| 208 | RLMD | Relmada Therapeutics, Inc. | 682.84M | 1.48% | 1,435,631 | - |
| 209 | CRMD | CorMedix Inc. | 680.18M | -1.81% | 811,405 | 400.05M |
| 210 | FDMT | 4D Molecular Therapeutics, Inc. | 673.84M | -1.00% | 642,519 | 88.24M |
| 211 | SGP | SpyGlass Pharma, Inc. | 671.01M | -1.91% | 136,659 | - |
| 212 | TECX | Tectonic Therapeutic, Inc. | 665.52M | -0.59% | 216,249 | - |
| 213 | ACHV | Achieve Life Sciences, Inc. | 657.02M | 3.06% | 1,721,126 | - |
| 214 | AGMB | AgomAb Therapeutics NV | 641.70M | 2.28% | 54,345 | - |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 635.61M | 7.28% | 1,201,285 | 151.40M |
| 216 | MDXG | MiMedx Group, Inc. | 616.64M | -2.82% | 1,034,983 | 389.42M |
| 217 | EIKN | Eikon Therapeutics, Inc. | 607.44M | 4.66% | 521,522 | - |
| 218 | ALT | Altimmune, Inc. | 606.76M | 0.32% | 2,876,992 | 36.00K |
| 219 | NVCT | Nuvectis Pharma, Inc. | 598.67M | 1.28% | 338,143 | - |
| 220 | KYTX | Kyverna Therapeutics, Inc. | 596.40M | -1.01% | 981,841 | - |
| 221 | CTNM | Contineum Therapeutics, Inc. | 577.62M | -1.28% | 280,674 | - |
| 222 | XOMA | XOMA Royalty Corporation | 561.84M | -0.44% | 375,675 | 48.56M |
| 223 | CBIO | Crescent Biopharma, Inc. | 556.92M | -0.30% | 168,652 | 11.88M |
| 224 | ASMB | Assembly Biosciences, Inc. | 552.31M | -2.99% | 179,142 | 71.10M |
| 225 | ARVN | Arvinas, Inc. | 551.01M | -0.23% | 456,282 | 89.40M |
| 226 | PROK | ProKidney Corp. | 543.71M | -2.17% | 1,508,432 | 889.00K |
| 227 | STTK | Shattuck Labs, Inc. | 539.06M | 2.18% | 643,597 | 1.00M |
| 228 | RZLT | Rezolute, Inc. | 535.91M | 3.43% | 1,407,412 | - |
| 229 | ZURA | Zura Bio Limited | 523.44M | 0.36% | 1,103,514 | - |
| 230 | CABA | Cabaletta Bio, Inc. | 507.92M | -0.48% | 6,365,678 | - |
| 231 | EDIT | Editas Medicine, Inc. | 506.42M | -10.08% | 3,489,907 | 38.69M |
| 232 | PRTA | Prothena Corporation plc | 504.69M | -2.13% | 482,222 | 57.94M |
| 233 | OCGN | Ocugen, Inc. | 497.63M | -2.00% | 5,451,136 | 4.47M |
| 234 | STRO | Sutro Biopharma, Inc. | 496.95M | -5.81% | 248,219 | 99.61M |
| 235 | VALN | Valneva SE | 495.80M | 0.75% | 9,652 | 180.25M |
| 236 | PRLD | Prelude Therapeutics Incorporated | 486.96M | -4.10% | 309,224 | 16.72M |
| 237 | EVMN | Evommune, Inc. | 486.61M | 1.96% | 1,444,535 | 10.00M |
| 238 | OVID | Ovid Therapeutics Inc. | 485.26M | -4.76% | 1,859,958 | 7.12M |
| 239 | VSTM | Verastem, Inc. | 474.52M | 6.30% | 5,131,389 | 49.59M |
| 240 | CCCC | C4 Therapeutics, Inc. | 474.33M | 2.39% | 2,536,283 | 34.86M |
| 241 | SLN | Silence Therapeutics plc | 465.73M | -0.90% | 232,687 | 839.00K |
| 242 | BNTC | Benitec Biopharma Inc. | 463.10M | - | 56,991 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 457.52M | -1.18% | 2,855,533 | - |
| 244 | ARTV | Artiva Biotherapeutics, Inc. | 457.21M | 1.07% | 261,160 | 251.00K |
| 245 | SGMT | Sagimet Biosciences Inc. | 453.88M | -1.21% | 573,002 | - |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 451.89M | -0.14% | 178,627 | - |
| 247 | AUTL | Autolus Therapeutics plc | 449.78M | -0.59% | 1,111,045 | 92.62M |
| 248 | LRMR | Larimar Therapeutics, Inc. | 431.10M | 14.40% | 3,823,932 | - |
| 249 | ANL | Adlai Nortye Ltd. | 427.20M | 4.91% | 215,020 | 5.00M |
| 250 | UPB | Upstream Bio, Inc. | 425.02M | -2.13% | 467,481 | 3.32M |
| 251 | IPSC | Century Therapeutics, Inc. | 416.62M | -4.94% | 1,292,464 | 109.16M |
| 252 | CMPX | Compass Therapeutics, Inc. | 416.00M | -1.28% | 1,971,912 | 850.00K |
| 253 | DMAC | DiaMedica Therapeutics Inc. | 415.44M | -3.20% | 190,232 | - |
| 254 | VTVT | vTv Therapeutics Inc. | 414.97M | -3.44% | 29,038 | 36.84M |
| 255 | ENTA | Enanta Pharmaceuticals, Inc. | 414.37M | -1.66% | 162,968 | 69.21M |
| 256 | HELP | Cybin Inc. | 410.95M | 6.42% | 1,902,330 | - |
| 257 | ABEO | Abeona Therapeutics Inc. | 405.81M | 4.71% | 2,608,181 | 14.54M |
| 258 | PBYI | Puma Biotechnology, Inc. | 402.11M | -2.83% | 464,170 | 227.18M |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 396.53M | -4.36% | 971,123 | - |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 392.93M | 2.08% | 313,244 | - |
| 261 | VNDA | Vanda Pharmaceuticals Inc. | 383.66M | -3.04% | 647,779 | 217.78M |
| 262 | VCRE | Vicore Pharma Holding AB (publ) | 374.17M | -1.66% | 21,888 | 370.61K |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 373.51M | - | 447,292 | 9.01M |
| 264 | FATE | Fate Therapeutics, Inc. | 362.50M | 6.14% | 3,050,950 | 6.32M |
| 265 | FENC | Fennec Pharmaceuticals Inc. | 358.14M | 0.59% | 98,603 | 51.00M |
| 266 | LYEL | Lyell Immunopharma, Inc. | 354.91M | -1.23% | 137,360 | 31.00K |
| 267 | FHTX | Foghorn Therapeutics Inc. | 352.87M | -2.59% | 392,268 | 28.22M |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 347.66M | -1.45% | 621,001 | 1.00 |
| 269 | IMRX | Immuneering Corporation | 346.78M | -3.07% | 1,053,052 | - |
| 270 | PALI | Palisade Bio, Inc. | 341.95M | -3.90% | 4,785,786 | - |
| 271 | ZNTL | Zentalis Pharmaceuticals, Inc. | 334.58M | -3.29% | 895,954 | 26.87M |
| 272 | IRD | Opus Genetics, Inc. | 331.91M | -1.95% | 868,815 | 11.98M |
| 273 | OABI | OmniAb, Inc. | 324.74M | -2.61% | 497,138 | 28.94M |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 321.59M | -3.73% | 1,161,891 | 14.78M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 319.26M | -1.90% | 1,422,180 | - |
| 276 | NMRA | Neumora Therapeutics, Inc. | 305.72M | 3.77% | 981,735 | - |
| 277 | IFRX | InflaRx N.V. | 303.42M | -4.63% | 846,783 | 33.82K |
| 278 | SABS | SAB Biotherapeutics, Inc. | 302.80M | 5.04% | 634,054 | 114.70K |
| 279 | BCYC | Bicycle Therapeutics plc | 291.81M | -2.34% | 577,307 | 63.50M |
| 280 | MGNX | MacroGenics, Inc. | 290.48M | -1.93% | 691,942 | 157.08M |
| 281 | GALT | Galectin Therapeutics Inc. | 287.79M | -3.10% | 430,319 | - |
| 282 | GLSI | Greenwich LifeSciences, Inc. | 287.25M | 3.71% | 116,835 | - |
| 283 | RNAC | Cartesian Therapeutics, Inc. | 284.12M | -5.66% | 117,480 | 1.78M |
| 284 | INDP | Indaptus Therapeutics, Inc. | 283.11M | 2.04% | 54,646 | - |
| 285 | NAGE | Niagen Bioscience, Inc. | 278.54M | 3.56% | 645,973 | 130.42M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 277.20M | -11.59% | 776,526 | - |
| 287 | SRZN | Surrozen, Inc. | 272.84M | 2.71% | 153,564 | 7.49M |
| 288 | TRDA | Entrada Therapeutics, Inc. | 266.65M | 1.09% | 603,163 | 5.74M |
| 289 | CNXU | Conexeu Sciences Inc. | 265.18M | -3.22% | 84,906 | - |
| 290 | TTRX | Turn Therapeutics Inc. | 262.43M | -4.13% | 193,101 | - |
| 291 | ACIU | AC Immune SA | 257.92M | 3.17% | 289,856 | 4.62M |
| 292 | ADAG | Adagene Inc. | 254.38M | 0.52% | 270,141 | 7.67M |
| 293 | CHRS | Coherus Oncology, Inc. | 251.43M | -1.21% | 1,228,810 | 46.88M |
| 294 | AVXL | Anavex Life Sciences Corp. | 250.21M | - | 895,748 | - |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 249.62M | 2.14% | 24,828 | 18.47M |
| 296 | PRQR | ProQR Therapeutics N.V. | 248.37M | 4.76% | 1,924,103 | 15.73M |
| 297 | NAUT | Nautilus Biotechnology, Inc. | 241.45M | 6.74% | 2,249,707 | - |
| 298 | FULC | Fulcrum Therapeutics, Inc. | 239.21M | -3.75% | 1,877,691 | 80.00M |
| 299 | KROS | Keros Therapeutics, Inc. | 238.10M | 3.08% | 371,361 | 33.18M |
| 300 | IVVD | Invivyd, Inc. | 236.78M | -3.17% | 2,301,080 | 55.87M |
| 301 | DTIL | Precision BioSciences, Inc. | 236.35M | -1.29% | 734,443 | 45.07M |
| 302 | TARA | Protara Therapeutics, Inc. | 236.06M | 2.19% | 530,829 | - |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 234.73M | - | 203,737 | 32.72M |
| 304 | CGEN | Compugen Ltd. | 233.62M | 2.49% | 427,749 | 72.66M |
| 305 | CDXS | Codexis, Inc. | 232.70M | -1.54% | 493,852 | 78.09M |
| 306 | KPTI | Karyopharm Therapeutics Inc. | 231.16M | -4.40% | 281,011 | 151.12M |
| 307 | NKTX | Nkarta, Inc. | 229.66M | -12.53% | 1,021,080 | - |
| 308 | CAMP | Camp4 Therapeutics Corporation | 225.36M | 3.58% | 187,374 | 3.93M |
| 309 | CLLS | Cellectis S.A. | 224.25M | 2.69% | 7,599 | 75.11M |
| 310 | VYGR | Voyager Therapeutics, Inc. | 222.35M | -1.34% | 505,557 | 36.49M |
| 311 | RNA | Atrium Therapeutics, Inc. | 220.83M | -3.44% | 239,511 | 36.68M |
| 312 | NERV | Minerva Neurosciences, Inc. | 219.43M | 1.95% | 195,394 | - |
| 313 | NBP | NovaBridge Biosciences | 215.11M | -3.63% | 506,397 | - |
| 314 | QTTB | Q32 Bio Inc. | 213.48M | -10.58% | 265,258 | 53.74M |
| 315 | TNXP | Tonix Pharmaceuticals Holding Corp. | 207.71M | 1.96% | 740,766 | 17.56M |
| 316 | WHWK | Whitehawk Therapeutics, Inc. | 207.60M | -2.53% | 481,582 | 7.15M |
| 317 | KRRO | Korro Bio, Inc. | 206.24M | -2.85% | 163,450 | 3.84M |
| 318 | ARCT | Arcturus Therapeutics Holdings Inc. | 203.51M | -1.92% | 890,141 | 54.71M |
| 319 | OTLK | Outlook Therapeutics, Inc. | 203.05M | -0.59% | 10,430,813 | 333.14K |
| 320 | IMUX | Immunic, Inc. | 201.33M | 0.07% | 122,190 | - |
| 321 | NGEN | NervGen Pharma Corp. | 197.54M | 0.54% | 779,208 | - |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 195.01M | -1.10% | 271,182 | - |
| 323 | CRBU | Caribou Biosciences, Inc. | 192.41M | - | 2,207,160 | 11.20M |
| 324 | PLX | Protalix BioTherapeutics, Inc. | 190.95M | -0.42% | 504,153 | 76.38M |
| 325 | MDWD | MediWound Ltd. | 189.06M | 0.07% | 48,819 | 14.48M |
| 326 | HUMA | Humacyte, Inc. | 188.83M | -4.49% | 10,114,755 | 2.02M |
| 327 | EQ | Equillium, Inc. | 187.15M | -6.03% | 2,615,405 | 4.39M |
| 328 | ACOG | Alpha Cognition Inc. | 185.52M | 0.24% | 28,601 | 10.83M |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 184.45M | -3.40% | 3,575,815 | 225.00K |
| 330 | LENZ | LENZ Therapeutics, Inc. | 181.54M | -5.55% | 787,307 | 20.99M |
| 331 | ALEC | Alector, Inc. | 181.53M | -10.66% | 589,285 | 18.42M |
| 332 | OKUR | OnKure Therapeutics, Inc. | 180.16M | -0.45% | 166,170 | - |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 178.98M | 1.15% | 230,175 | - |
| 334 | MIST | Milestone Pharmaceuticals Inc. | 178.23M | 7.38% | 809,134 | 1.78M |
| 335 | ARMP | Armata Pharmaceuticals, Inc. | 177.31M | -5.29% | 249,717 | 5.20M |
| 336 | NRXP | NRx Pharmaceuticals, Inc. | 172.25M | 4.85% | 774,475 | 2.29M |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 171.07M | -2.56% | 311,498 | 2.00M |
| 338 | IPHA | Innate Pharma S.A. | 170.75M | -2.72% | 2,325 | 10.57M |
| 339 | MENS | Jyong Biotech Ltd. | 170.74M | 4.55% | 32,633 | - |
| 340 | CNTB | Connect Biopharma Holdings Limited | 167.48M | 19.82% | 2,467,034 | 233.00K |
| 341 | PYXS | Pyxis Oncology, Inc. | 167.26M | -1.86% | 725,231 | 13.86M |
| 342 | ANTX | AN2 Therapeutics, Inc. | 166.75M | 4.99% | 99,070 | - |
| 343 | TLSA | Tiziana Life Sciences Ltd | 162.93M | 0.80% | 262,727 | - |
| 344 | CNTN | Canton Strategic Holdings, Inc. | 159.85M | -1.29% | 891,688 | - |
| 345 | PEPG | PepGen Inc. | 159.09M | 15.58% | 2,434,993 | - |
| 346 | CUE | Cue Biopharma, Inc. | 153.35M | 3.28% | 143,821 | 32.73M |
| 347 | YDES | YD Bio Limited | 150.48M | 9.18% | 51,296 | 510.36K |
| 348 | MOLN | Molecular Partners AG | 149.26M | -1.62% | 2,345 | 856.30K |
| 349 | HURA | TuHURA Biosciences, Inc. | 149.02M | 2.63% | 257,051 | - |
| 350 | KZIA | Kazia Therapeutics Limited | 148.32M | 4.17% | 235,732 | 1.27M |
| 351 | CBUS | Cibus, Inc. | 145.03M | 4.40% | 856,032 | 4.29M |
| 352 | SPRB | Spruce Biosciences, Inc. | 142.40M | 3.90% | 57,121 | 697.00K |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 140.44M | -3.13% | 1,062,087 | - |
| 354 | ALDX | Aldeyra Therapeutics, Inc. | 138.74M | 7.98% | 2,084,733 | - |
| 355 | AGEN | Agenus Inc. | 134.92M | -0.31% | 654,170 | 123.87M |
| 356 | VANI | Vivani Medical, Inc. | 134.53M | -2.50% | 1,230,600 | - |
| 357 | GNLX | Genelux Corporation | 132.34M | 0.68% | 124,840 | 8.00K |
| 358 | ENGN | enGene Therapeutics Inc. | 128.62M | 3.23% | 1,360,161 | - |
| 359 | NMAD | NOMAD Power Solutions, Inc. | 127.98M | -9.38% | 339,853 | - |
| 360 | PMN | ProMIS Neurosciences, Inc. | 127.97M | 3.56% | 43,448 | - |
| 361 | GUTS | Fractyl Health, Inc. | 125.57M | 3.86% | 442,530 | 3.00K |
| 362 | COYA | Coya Therapeutics, Inc. | 123.38M | -1.87% | 264,258 | 7.94M |
| 363 | SPRO | Spero Therapeutics, Inc. | 122.75M | -2.30% | 369,688 | 61.19M |
| 364 | SEER | Seer, Inc. | 120.96M | 0.92% | 419,281 | 15.17M |
| 365 | ENLV | Enlivex Ltd. | 118.92M | 2.64% | 98,161 | - |
| 366 | NTHI | NeOnc Technologies Holdings, Inc. | 116.44M | - | 41,937 | 39.99K |
| 367 | PLYX | Polaryx Therapeutics, Inc. | 115.04M | -4.71% | 108,951 | - |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 112.18M | -1.36% | 35,236 | 37.16M |
| 369 | ONCY | Oncolytics Biotech Inc. | 109.81M | 16.12% | 2,206,258 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 109.55M | 3.54% | 100,694 | - |
| 371 | FBIO | Fortress Biotech, Inc. | 109.29M | 9.67% | 1,239,709 | 66.16M |
| 372 | AARD | Aardvark Therapeutics, Inc. | 109.08M | -5.30% | 402,760 | - |
| 373 | BDTX | Black Diamond Therapeutics, Inc. | 107.73M | -1.05% | 762,317 | 70.00M |
| 374 | KLRS | Kalaris Therapeutics, Inc. | 106.83M | -4.88% | 14,810 | - |
| 375 | PYPD | PolyPid Ltd. | 103.92M | 4.03% | 319,950 | - |
| 376 | ICCC | ImmuCell Corporation | 103.63M | 7.76% | 49,053 | 29.93M |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 97.91M | -1.65% | 1,184,905 | 65.34K |
| 378 | CGTX | Cognition Therapeutics, Inc. | 97.55M | 1.87% | 1,983,655 | - |
| 379 | ATHE | Alterity Therapeutics Limited | 97.40M | -3.58% | 12,886 | 4.43M |
| 380 | ALPS | Alps Group Inc | 94.85M | -1.98% | 42,492 | 3.74M |
| 381 | BMEA | Biomea Fusion, Inc. | 94.71M | 0.77% | 757,100 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 94.40M | -3.00% | 8,953 | 27.70M |
| 383 | ACET | Adicet Bio, Inc. | 93.88M | -3.35% | 98,265 | - |
| 384 | RNTX | Rein Therapeutics Inc. | 92.83M | 2.87% | 313,487 | - |
| 385 | CRDF | Cardiff Oncology, Inc. | 90.25M | 5.60% | 956,311 | 525.00K |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 89.61M | 3.06% | 45,225 | 23.14M |
| 387 | NRXS | NeurAxis, Inc. | 89.29M | 1.84% | 24,447 | 4.28M |
| 388 | MAIA | MAIA Biotechnology, Inc. | 88.77M | -0.68% | 547,759 | - |
| 389 | LONA | LeonaBio, Inc. | 88.21M | 8.30% | 5,892 | - |
| 390 | OKYO | OKYO Pharma Limited | 88.17M | 1.20% | 78,850 | - |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 87.74M | 0.49% | 754,246 | - |
| 392 | TELO | Telomir Pharmaceuticals, Inc. | 87.34M | 2.42% | 92,349 | - |
| 393 | RANI | Rani Therapeutics Holdings, Inc. | 86.50M | 0.75% | 603,296 | 3.17M |
| 394 | GOSS | Gossamer Bio, Inc. | 85.55M | 3.55% | 8,708,902 | 55.54M |
| 395 | RLYB | Rallybio Corporation | 83.87M | 0.96% | 61,483 | 858.00K |
| 396 | ENTX | Entera Bio Ltd. | 83.79M | 0.59% | 105,042 | 42.00K |
| 397 | ANVS | Annovis Bio, Inc. | 82.96M | -2.01% | 1,048,528 | - |
| 398 | HRTX | Heron Therapeutics, Inc. | 81.11M | -3.82% | 1,569,333 | 150.71M |
| 399 | CSBR | Champions Oncology, Inc. | 80.68M | -4.28% | 10,851 | 57.95M |
| 400 | GANX | Gain Therapeutics, Inc. | 77.63M | 1.68% | 589,393 | - |
| 401 | OSTX | OS Therapies Incorporated | 76.61M | 17.81% | 1,339,470 | - |
| 402 | IBIO | iBio, Inc. | 75.01M | -0.66% | 1,160,568 | 300.00K |
| 403 | HYFT | MindWalk Holdings Corp. | 72.51M | 1.39% | 104,490 | 20.70M |
| 404 | XBIT | XBiotech Inc. | 69.82M | -2.97% | 24,870 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 69.44M | -0.88% | 1,482,642 | - |
| 406 | TCRX | TScan Therapeutics, Inc. | 69.27M | -15.87% | 1,266,274 | 9.14M |
| 407 | MNOV | MediciNova, Inc. | 67.93M | -1.43% | 27,832 | 596.64K |
| 408 | CING | Cingulate Inc. | 66.67M | 2.27% | 190,462 | - |
| 409 | ELTX | Elicio Therapeutics, Inc. | 66.56M | - | 1,047,947 | - |
| 410 | IMA | ImageneBio, Inc. | 66.55M | -0.51% | 14,103 | 800.00K |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 66.13M | -0.80% | 105,418 | - |
| 412 | MCRB | Seres Therapeutics, Inc. | 65.27M | -5.60% | 121,932 | 1.15M |
| 413 | VRXA | Veraxa Biotech AG | 62.54M | -10.14% | 695,208 | - |
| 414 | EDSA | Edesa Biotech, Inc. | 62.42M | -3.97% | 66,614 | - |
| 415 | BYSI | BeyondSpring Inc. | 61.27M | -10.78% | 71,637 | 1.88M |
| 416 | EXOZ | eXoZymes, Inc. | 60.03M | -6.23% | 11,182 | -700.00 |
| 417 | FLNA | Filana Therapeutics, Inc. | 57.49M | 0.85% | 434,734 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 57.09M | 8.63% | 35,699 | - |
| 419 | ATYR | aTyr Pharma, Inc. | 57.04M | -9.55% | 1,466,971 | 190.00K |
| 420 | BOLD | Boundless Bio, Inc. | 56.38M | 2.45% | 148,404 | - |
| 421 | XLO | Xilio Therapeutics, Inc. | 55.04M | -0.86% | 19,945 | 53.48M |
| 422 | CNTX | Context Therapeutics Inc. | 54.62M | -0.18% | 11,713,911 | - |
| 423 | IMMP | Immutep Limited | 53.20M | -1.61% | 106,889 | 5.28M |
| 424 | TIL | Instil Bio, Inc. | 51.95M | -1.54% | 15,855 | - |
| 425 | MREO | Mereo BioPharma Group plc | 51.75M | 2.59% | 769,620 | 500.00K |
| 426 | CRVO | CervoMed Inc. | 50.59M | 9.68% | 396,841 | 2.09M |
| 427 | RADX | Radiopharm Theranostics Limited | 49.21M | -1.06% | 20,398 | 10.86M |
| 428 | IBO | Impact BioMedical Inc. | 48.79M | 0.18% | 26,944 | 39.00K |
| 429 | ELOX | Eloxx Pharmaceuticals, Inc. | 48.03M | -2.86% | 133,321 | - |
| 430 | INMB | INmune Bio Inc. | 47.59M | 4.07% | 1,285,504 | 50.00K |
| 431 | MGX | Metagenomi Therapeutics, Inc. | 47.44M | -2.33% | 190,943 | 22.33M |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 47.42M | - | 32,150 | - |
| 433 | HYPD | Hyperion DeFi, Inc. | 47.29M | 5.05% | 140,765 | 1.04M |
| 434 | VERU | Veru Inc. | 45.10M | 5.64% | 179,429 | 16.89M |
| 435 | PDSB | PDS Biotechnology Corporation | 43.94M | -4.57% | 791,557 | - |
| 436 | LTRN | Lantern Pharma Inc. | 42.74M | 8.06% | 340,871 | - |
| 437 | RNXT | RenovoRx, Inc. | 42.38M | 4.42% | 132,854 | 1.49M |
| 438 | ALGS | Aligos Therapeutics, Inc. | 41.89M | 0.59% | 195,725 | 4.71M |
| 439 | APLM | Apollomics, Inc. | 41.29M | -1.62% | 1,802 | 8.84M |
| 440 | ESLA | Estrella Immunopharma, Inc. | 40.90M | 5.61% | 49,120 | - |
| 441 | GRCE | Grace Therapeutics, Inc. | 39.71M | -2.01% | 209,985 | - |
| 442 | DYAI | Dyadic International, Inc. | 38.99M | 7.33% | 156,954 | 3.81M |
| 443 | NTRB | Nutriband Inc. | 37.56M | 0.98% | 9,964 | 1.80M |
| 444 | GNTA | Genenta Science S.p.A. | 37.51M | 3.92% | 53,981 | - |
| 445 | NNVC | NanoViricides, Inc. | 36.68M | 3.87% | 436,219 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 36.64M | -28.22% | 520,879 | 797.92K |
| 447 | TVRD | Tvardi Therapeutics, Inc. | 35.65M | -24.00% | 7,485,612 | - |
| 448 | LITS | Lite Strategy, Inc. | 33.79M | 1.65% | 78,019 | - |
| 449 | SER | Serina Therapeutics, Inc. | 32.99M | 10.00% | 67,751 | 130.00K |
| 450 | BCTX | BriaCell Therapeutics Corp. | 31.75M | -1.62% | 157,949 | - |
| 451 | SNTI | Senti Biosciences Holdings, Inc. | 31.14M | -3.85% | 181,285 | 38.00K |
| 452 | DARE | Daré Bioscience, Inc. | 31.01M | 1.97% | 121,164 | 1.16M |
| 453 | ATNM | Actinium Pharmaceuticals, Inc. | 30.43M | - | 39,291 | 90.00K |
| 454 | KYNB | Kyntra Bio, Inc. | 29.63M | -2.27% | 17,171 | 7.44M |
| 455 | LSTA | Lisata Therapeutics, Inc. | 29.46M | 0.78% | 12,297 | 170.00K |
| 456 | ACTU | Actuate Therapeutics, Inc. | 29.43M | -7.52% | 663,710 | - |
| 457 | IGC | IGC Pharma, Inc. | 27.93M | 1.42% | 982,323 | 1.11M |
| 458 | GRDX | GridAI Technologies Corp. | 27.68M | -3.26% | 18,516 | - |
| 459 | PSTV | Plus Therapeutics, Inc. | 27.53M | 4.71% | 47,159 | 5.18M |
| 460 | PLRZ | Polyrizon Ltd. | 26.88M | -1.71% | 8,175 | - |
| 461 | EVAX | Evaxion A/S | 26.69M | -1.54% | 22,061 | 7.53M |
| 462 | MRKR | Marker Therapeutics, Inc. | 26.34M | -1.86% | 38,965 | 3.55M |
| 463 | BRNS | Barinthus Biotherapeutics plc | 26.06M | 0.08% | 37,235 | 14.97M |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 25.10M | 0.20% | 53,950 | - |
| 465 | KALA | KALA BIO, Inc. | 25.10M | -2.88% | 97,528 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 24.63M | -0.30% | 48,316 | - |
| 467 | TVGN | Tevogen Bio Holdings Inc. | 23.62M | 8.46% | 7,896 | - |
| 468 | CVM | CEL-SCI Corporation | 23.59M | -4.26% | 229,508 | - |
| 469 | AKTX | Akari Therapeutics, Plc | 23.04M | -7.39% | 14,968 | - |
| 470 | VYNE | VYNE Therapeutics Inc. | 22.41M | 3.35% | 27,044 | 454.00K |
| 471 | NCEL | NewcelX Ltd. | 22.24M | -2.36% | 131,132 | - |
| 472 | CLRB | Cellectar Biosciences, Inc. | 22.14M | 2.97% | 19,720 | - |
| 473 | QNTM | Quantum BioPharma Ltd. | 21.72M | 4.28% | 63,666 | - |
| 474 | CELU | Celularity Inc. | 21.65M | 2.51% | 92,307 | 26.55M |
| 475 | LGVN | Longeveron Inc. | 20.55M | 1.17% | 199,293 | 1.22M |
| 476 | LPCN | Lipocine Inc. | 20.36M | 1.23% | 6,479 | 2.00M |
| 477 | ATOS | Atossa Therapeutics, Inc. | 20.32M | -3.67% | 144,081 | - |
| 478 | ICU | SeaStar Medical Holding Corporation | 19.70M | -3.54% | 65,276 | 1.44M |
| 479 | PLUR | Pluri Inc. | 19.21M | -6.32% | 71,596 | 1.08M |
| 480 | ALLR | Allarity Therapeutics, Inc. | 19.09M | 3.45% | 55,727 | 345.00K |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 18.97M | -0.28% | 14,785 | -13.27K |
| 482 | PTN | Palatin Technologies, Inc. | 18.45M | 2.14% | 7,876 | 12.88M |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 18.39M | 5.20% | 592,304 | 1.14M |
| 484 | QNCX | Quince Therapeutics, Inc. | 17.10M | 1.39% | 4,667 | - |
| 485 | BIVI | BioVie Inc. | 16.89M | 2.75% | 111,967 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 16.71M | -2.25% | 259,266 | - |
| 487 | CYCN | Cyclerion Therapeutics, Inc. | 16.67M | 13.09% | 104,495 | 1.99M |
| 488 | JSPR | Jasper Therapeutics, Inc. | 16.28M | 12.98% | 471,826 | - |
| 489 | GTBP | GT Biopharma, Inc. | 16.13M | -4.36% | 844,317 | - |
| 490 | HIND | Vyome Holdings, Inc. | 15.65M | 4.69% | 26,033 | 152.72K |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 15.41M | 0.72% | 196,439 | 5.61M |
| 492 | MLEC | Moolec Science SA | 15.25M | -5.30% | 3,709 | 7.83M |
| 493 | LEXX | Lexaria Bioscience Corp. | 15.24M | 1.65% | 127,118 | 368.00K |
| 494 | CALC | CalciMedica, Inc. | 15.01M | 5.54% | 305,139 | - |
| 495 | PASG | Passage Bio, Inc. | 14.79M | -4.36% | 19,439 | - |
| 496 | TPST | Tempest Therapeutics, Inc. | 14.43M | -1.27% | 61,010 | - |
| 497 | COCP | Cocrystal Pharma, Inc. | 13.93M | 2.85% | 7,294 | 225.00K |
| 498 | INAB | IN8bio, Inc. | 13.79M | 1.45% | 70,181 | - |
| 499 | INTS | Intensity Therapeutics, Inc. | 13.27M | 0.20% | 16,438 | - |
| 500 | AEON | AEON Biopharma, Inc. | 13.22M | -28.24% | 545,915 | - |